Seamless mobile clinical services increase patient recruitment and retention in rare pediatric disease trials

Case study: Transforming a Long-Term FSP partnership to enhance global oncology studies

Fortrea’s decade-long Functional Service Provider (FSP) partnership with a global sponsor showcases how trust, agility, and collaboration can transform oncology research.

Natural history research is powering more effective decision-making in oncology clinical trials

Synthetic control arms are reducing placebo use in oncology trials, helping more patients have access to potential life-saving drugs and allowing for faster trials and reduced time to market.

Anshul Thakral

Anshul Thakral is Chief Executive Officer of Fortrea (Nasdaq: FTRE), having joined the company in August 2025. He also serves as a member of Fortrea’s Board of Directors.

Experts highlight how CRO-site partnerships advance phase III CV trials

Leveraging expedited programs in oncology: How accelerated approval helps drug developers get cancer drugs to patients faster